29332-74-9 Usage
Description
(Z)-N-(carboxymethyl)-N-(1-oxo-9-octadecenyl)glycine, also known as (Z)-2-[(1-oxo-9-octadecenyl)amino]acetic acid, is a chemical compound derived from the amino acid glycine. It features a carboxymethyl group attached to the nitrogen atom of glycine and a long hydrocarbon chain with a double bond. (Z)-N-(carboxymethyl)-N-(1-oxo-9-octadecenyl)glycine is commonly found in lipids and has demonstrated potential effects on lipid metabolism and inflammation. Its unique structure and properties make it a candidate for various applications in the pharmaceutical and biotechnological industries.
Uses
Used in Pharmaceutical Development:
(Z)-N-(carboxymethyl)-N-(1-oxo-9-octadecenyl)glycine is used as a key compound for the development of new pharmaceuticals, due to its potential effects on lipid metabolism and inflammation. Its ability to modulate these biological processes may lead to the creation of novel treatments for conditions related to lipid imbalances and inflammatory diseases.
Used in Biotechnological Products:
In the biotechnology industry, (Z)-N-(carboxymethyl)-N-(1-oxo-9-octadecenyl)glycine is used as a building block for the synthesis of complex molecules with specific biological activities. Its unique structure allows for the development of targeted therapies and advanced drug delivery systems, potentially improving the efficacy and safety of various treatments.
Used in Lipid Metabolism Research:
(Z)-N-(carboxymethyl)-N-(1-oxo-9-octadecenyl)glycine is used as a research tool for studying the role of lipids in cellular processes. Its presence in lipids and its potential effects on lipid metabolism make it a valuable compound for understanding the underlying mechanisms of lipid-related diseases and for identifying new therapeutic targets.
Used in Inflammation Studies:
As a compound with potential effects on inflammation, (Z)-N-(carboxymethyl)-N-(1-oxo-9-octadecenyl)glycine is used in the study of inflammatory processes and the development of anti-inflammatory agents. Its involvement in these processes may provide insights into the pathogenesis of various inflammatory diseases and contribute to the development of new treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 29332-74-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,3,3 and 2 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 29332-74:
(7*2)+(6*9)+(5*3)+(4*3)+(3*2)+(2*7)+(1*4)=119
119 % 10 = 9
So 29332-74-9 is a valid CAS Registry Number.
InChI:InChI=1/C22H39NO5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(24)23(18-21(25)26)19-22(27)28/h9-10H,2-8,11-19H2,1H3,(H,25,26)(H,27,28)/b10-9-
29332-74-9Relevant articles and documents
Design and synthesis of lipids for the fabrication of functional lipidic cubic-phase biomaterials
Osornio, Yazmin M.,Uebelhart, Peter,Bosshard, Silvan,Konrad, Fabian,Siegel, Jay S.,Landau, Ehud M.
, p. 10583 - 10595 (2013/02/22)
A series of novel lipids with designed functionalities were synthesized. These lipids are based on conjugation of α-amino acids and their esters, cationic, anionic, neutral, and photochromic moieties to the lipophilic 9-cis octadecenyl chains by amide, ester, thioester, or amine bonds. Because of the plasticity of lipidic cubic phases, it is envisaged that when mixed with monooleoyl-rac-glycerol (monoolein, MO) and water at appropriate proportions, they would assemble to form bicontinuous lipidic cubic phases (LCPs) that exhibit the well-known material properties of LCPs such as phase stability, optical transparency, and chemical permeability. Moreover, due to the nature and position of the functionality at the headgroup region, we envision them to perform as functional materials by design.
